Cordycepin Accelerates Osteoblast Mineralization and Attenuates Osteoclast Differentiation In Vitro

about

Cordycepin Accelerates Osteoblast Mineralization and Attenuates Osteoclast Differentiation In Vitro

Item

http://www.wikidata.org/entity/Q58553046

description

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 16 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована у 2018

@uk

name

Cordycepin Accelerates Osteobl ...... clast Differentiation In Vitro

@en

Cordycepin Accelerates Osteobl ...... clast Differentiation In Vitro

@nl

type

Item

label

Cordycepin Accelerates Osteobl ...... clast Differentiation In Vitro

@en

Cordycepin Accelerates Osteobl ...... clast Differentiation In Vitro

@nl

prefLabel

Cordycepin Accelerates Osteobl ...... clast Differentiation In Vitro

@en

Cordycepin Accelerates Osteobl ...... clast Differentiation In Vitro

@nl

P1476

Cordycepin Accelerates Osteobl ...... clast Differentiation In Vitro

@en

P2093

Hae-Mi Kang

http://www.w3.org/2001/XMLSchema#string

Ji-Hye Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic analysis of the roles of BMP2, BMP4, and BMP7 in limb patterning and skeletogenesis

Receptor activator of NF-kappaB ligand (RANKL) activates TAK1 mitogen-activated protein kinase kinase kinase through a signaling complex containing RANK, TAB2, and TRAF6

Anticancer and antimetastatic effects of cordycepin, an active component of Cordyceps sinensis

RANKL-RANK signaling in osteoclastogenesis and bone disease

Antifungal activity of 3'-deoxyadenosine (cordycepin)

The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts

Effect of Traditional Chinese Medicine Product, QiangGuYin, on Bone Mineral Density and Bone Turnover in Chinese Postmenopausal Osteoporosis.

Bone Alkaline Phosphatase and Tartrate-Resistant Acid Phosphatase: Potential Co-regulators of Bone Mineralization

Sitagliptin, An Anti-diabetic Drug, Suppresses Estrogen Deficiency-Induced OsteoporosisIn Vivo and Inhibits RANKL-Induced Osteoclast Formation and Bone Resorption In Vitro.

Therapeutic approaches to bone diseases.

P304

5892957

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2018/5892957

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

2018

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30410556

http://www.w3.org/2001/XMLSchema#string

P932

6206560

http://www.w3.org/2001/XMLSchema#string